{% extends "layout.html" %}

{% block title %}Experimental Overview{% endblock %}
{% block lead %}Cell-based assays in HEK293T: A complete weekly workflow{% endblock %}

{% block page_content %}


<div class="page-container">
  <aside class="sidebar">
      <ul class="sidebar-nav">
          <li><a href="#basic" class="active">New Basic Parts</a></li>
          <li><a href="#composite" class="active">Composite Parts</a></li>
      </ul>
  
    <!--EXTRA INFO-->
    <!-- Functional RNA Element (FRE) -->
<div class="info-card" id="fre-info">
  <div class="card">
    <h3 class="card-title">Functional RNA Element (FRE)</h3>
    <p>RNA sequences that perform specific biological functions when folded, such as frameshift elements, ribozymes, or Stop Codon Readthrough<sup>[3]</sup> sequences.</p>
  </div>
</div>

<!-- Semi-rational design -->
<div class="info-card" id="semi-rational">
  <div class="card">
    <h3 class="card-title">Semi-rational design</h3>
    <p>Semi-rational design uses rational guidance to narrow down the possibilities, 
       even if the exact behaviour cannot be exactly predicted, while still relying on experimental 
       testing of a manageable set of candidates.</p>
  </div>
</div>

<!-- Conformational RNA Element (CRE) -->
<div class="info-card" id="cre-info">
  <div class="card">
    <h3 class="card-title">Conformational RNA Element (CRE)</h3>
    <p>RNA structures that can change conformation in response to stimuli, including Aptamer<sup>[4]</sup>s, miniRNAs, and temperature-sensitive motifs.</p>
  </div>
</div>

<!-- SECIS Element -->
<div class="info-card" id="secis-info">
  <div class="card">
    <h3 class="card-title">SECIS Element</h3>
    <p>A highly conserved RNA hairpin structure that directs the ribosome to bypass UGA stop codons and incorporate selenocysteine into proteins.</p>
  </div>
</div>

<!-- Aptamer -->
<div class="info-card" id="aptamer-info">
  <div class="card">
    <h3 class="card-title">Aptamer</h3>
    <p>A short RNA or DNA molecule that binds specifically to a target molecule (similar to an antibody in function).</p>
  </div>
</div>

<!-- Riboswitches -->
<div class="info-card" id="riboswitches">
  <div class="card">
    <h3 class="card-title">Riboswitches</h3>
    <p>Structured RNA segments that directly bind small molecules and regulate gene expression without requiring proteins. They change conformation upon ligand binding.</p>
  </div>
</div>

<!-- Model Section -->
<div class="info-card" id="model-info">
  <div class="card">
    <h3 class="card-title">Model Section</h3>
    <p>Explanation of the workflow from Engineering design to Wet Lab experiments.</p>
  </div>
</div>
<div class="info-card" id="hp-card1">
  <div class="card">
    <h3 class="card-title">HP CARD</h3>
    <p>
      At the <strong>Discover-Glo conference</strong> by <strong>Promega</strong>, we had the chance to talk to 
      <strong>Irena Montiel</strong> and <strong>Eric Rovira</strong>, who suggested using the 
      <strong>dual-luciferase assay</strong> to test our construct.
      See <a href="https://2025.igem.wiki/barcelona-ub/human-practices" class="highlight-word info-word" style="text-decoration: none;">HP</a>
      and <a href="https://2025.igem.wiki/barcelona-ub/engineering" class="highlight-word info-word" style="text-decoration: none;">Engineering</a>
    
    </p>
  </div>
</div>

        
    </aside>
   <div class="page-content">
    <div class="header">
      <h1 class="page-title">Experimental Overview</h1>
      <p class="page-desc"></p>
    </div>
     <div class="content">
    <h2 class="section-title">Organization</h2>
    <p>
        The experimental work of our project aims to complete the various cycles described in the Engineering section. In the table below, each wet lab branch is associated with the engineering cycle it seeks to complete and provide experimental validation for.
 </p>
 <br>
  <table class="parts-table" style="border-collapse: collapse; width: 100%; margin-bottom: 2rem;">
  <colgroup>
    <col style="width: 50%; border-right: 2px solid #ccc;">
    <col style="width: 50%;">
  </colgroup>

  <tr style="background-color: #f2f2f2;">
    <th style="padding: 10px; border-bottom: 2px solid #ccc;">Engineering</th>
    <th style="padding: 10px; border-bottom: 2px solid #ccc;">Wet Lab</th>
  </tr>

  <tr>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch:</strong> SCR-D structure prediction<br>
      &nbsp;&nbsp;<strong>Cycle 2:</strong> Identification of key structural elements<br>
      &nbsp;&nbsp;&nbsp;&nbsp;- Complete iteration 3
    </td>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch 1:</strong> SCR-D element
    </td>
  </tr>

  <tr>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch:</strong> Creation of an aptamer-controlled SCR<br>
      &nbsp;&nbsp;<strong>Cycle 2:</strong> Aptamer<br>
      &nbsp;&nbsp;&nbsp;&nbsp;- Complete iteration 2
    </td>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch 2:</strong> SECIS element
    </td>
  </tr>

  <tr>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch:</strong> Creation of an aptamer-controlled SCR<br>
      &nbsp;&nbsp;<strong>Cycle 3:</strong> Riboswitch<br>
      &nbsp;&nbsp;&nbsp;&nbsp;- Complete iteration 1
    </td>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch 3:</strong> Sensing element<br>
      <strong>Branch 4:</strong> Cell-free validation
    </td>
  </tr>

  <tr>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch:</strong> Creation of an aptamer-controlled SCR<br>
      &nbsp;&nbsp;<strong>Cycle 3:</strong> Switch<br>
      &nbsp;&nbsp;&nbsp;&nbsp;- Complete iteration 1
    </td>
    <td style="padding: 8px; border-bottom: 1px solid #ccc;">
      <strong>Branch 5:</strong> Switch
    </td>
  </tr>
</table>
<p>A detailed explanation of the workflow Engineering â†’ Wet Lab can be found in the <a class="link-text" href="https://2025.igem.wiki/barcelona-ub/model">Model Page</a>.</p>
<br><br>
<h1>Experimental workflow</h1>

<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/generalscheme.webp" 
    alt="General scheme of experimental workflow" 
    style="width: 80%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>

<p>In the laboratory, we mainly carried out two types of assays: <strong>cell-based assays</strong> and <strong>cell-free system assays</strong>. Both assays share a <strong>common preliminary part</strong>.</p>
<br><br>
<h2>Common part</h2>
<p>The constructs arrived from the supplier in plasmid form. In order to amplify the plasmids, we performed a standard amplification procedure using <strong>E. coli DH5Î±</strong>:</p>

<ol>
  <li><strong>Transformation:</strong> We carried out a bacterial transformation by heat shock of <strong>E. coli DH5Î±</strong> with the plasmids of interest, and plated the bacteria.</li>
  <li><strong>Incubation:</strong> The following day, we collected colonies from the plates and incubated them in tubes with <strong>LB medium</strong>.</li>
  <li><strong>Plasmid purification:</strong> One day later, we purified the plasmids of interest, obtaining the desired concentration.</li>
  <li><strong>Verification:</strong> Finally, to verify the efficiency of the procedure, we measured the concentration of the purified plasmids using a <strong>Nanodrop</strong>.</li>
</ol>

<p>All plasmids underwent this process before being used in the assays.</p>
<br><br>
<h2>Cell-based assays in HEK293T</h2>
<p>Starting from the purified plasmids, we performed the assays in HEK293T cells, with plasmids of SCR-D and SECIS. A complete assay takes one week, so we always began on Monday and finished over the weekend. The process is as follows:
</p>
        
 
    <div class="calendar-container">
        <div class="calendar-header">
            <h2 class="calendar-title">Weekly Experimental Timeline</h2>
            <p class="calendar-subtitle">From cell seeding to data analysis - a complete 7-day protocol</p>
        </div>

        <div class="week-grid">
            <!-- Day 1 - Monday -->
            <div class="day-card">
                <div class="day-header">
                    <div class="day-number">1</div>
                    <div class="day-name">Monday</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Cell Seeding</div>
                    <div class="activity-description">
                        We seeded the cells at the   <span class="highlight-word">desired density</span> in 48-well plates. The cells were then incubated for 24 hours.
                    </div>
                </div>
            </div>

            <!-- Day 2 - Tuesday -->
            <div class="day-card">
                <div class="day-header">
                    <div class="day-number">2</div>
                    <div class="day-name">Tuesday</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Transfection</div>
                    <div class="activity-description">
                        We transfected the   <span class="highlight-word">plasmids of interest</span> (SCR-D and SECIS) into the cells using a lipofectamine-based system, followed by a 24-hour incubation.
                    </div>
                </div>
            </div>

            <!-- Day 3 - Wednesday -->
            <div class="day-card">
                <div class="day-header">
                    <div class="day-number">3</div>
                    <div class="day-name">Wednesday</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Treatment</div>
                    <div class="activity-description">
                        After preparing   <span class="highlight-word">selenium and theophylline solutions</span>, we treated the cells with selenium and/or theophylline and incubated them for 48 hours.
                    </div>
                </div>
            </div>

            <!-- Day 4 - Thursday -->
            <div class="day-card">
                <div class="day-header">
                    <div class="day-number">4</div>
                    <div class="day-name">Thursday</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Observation</div>
                    <div class="activity-description">
                        We observed the cells under an   <span class="highlight-word">optical microscope</span>, solely to check that the process was proceeding correctly and that cell growth was taking place as expected.
                    </div>
                </div>
            </div>

            <!-- Day 5 - Friday -->
            <div class="day-card">
                <div class="day-header">
                    <div class="day-number">5</div>
                    <div class="day-name">Friday</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Luciferase Assay</div>
                    <div class="activity-description">
                        We performed   <span class="highlight-word">cell lysis and dual-luciferase assay</span> <span class = "highlight-word info-word" data-target="hp-card1">&#128161</span>(Dual-LuciferaseÂ® Reporter Assay System from PromegaÂ®, catalog #E1910), obtaining raw data on gene expression.
                    </div>
                </div>
            </div>

            <!-- Weekend -->
            <div class="day-card weekend-card">
                <div class="day-header">
                    <div class="day-number">ðŸ“Š</div>
                    <div class="day-name">Weekend</div>
                </div>
                <div class="day-content">
                    <div class="activity-title">Data Analysis & Presentation</div>
                    <div class="activity-description">
                        We dedicated this time to   <span class="highlight-word">plotting and analyzing the results in RStudio</span>, and prepared a presentation of the findings and conclusions to share with our PI and instructors.
                    </div>
                </div>
            </div>
        </div>
    </div>
   <p>This procedure shows variations across the different rounds carried out, since we have conducted an optimization process of the various variables and time points that influence the experiment. For more details about this process, please refer to the <a class="link-text" href="https://2025.igem.wiki/barcelona-ub/pivotal-changes">Pivotal changes and milestones Page</a>.</p>
  </div>
<br><br>
  <h2>Cell-free system assays</h2>

<p>Starting from the purified plasmids, we performed the <strong>cell-free system assays</strong> (<em>TnTÂ® Coupled Reticulocyte Lysate Systems</em> from PromegaÂ®, catalog #L1170), but in this case only <strong>SECIS plasmids</strong> and <strong>SECIS-related plasmids</strong> were tested. A complete assay takes one or two days. The process is as follows:</p>

<ol>
  <li><strong>Starting Material:</strong> The starting point can be either a purified plasmid or a PCR product. We incorporated <strong>Paul Copelandâ€™s plasmid</strong> in purified plasmid form. However, we performed a PCR on the SECIS plasmids to incorporate our construct as a PCR product, since in this form it was more stable. Therefore, the first step was to run a <strong>PCR</strong> and an <strong>agarose gel electrophoresis</strong>.</li>
  
  <li><strong>Assay Setup:</strong> Once we had the PCR product, we proceeded with the cell-free system assay. The different samples were treated with <strong>selenium</strong> and/or <strong>theophylline</strong>, which were added prior to the incubation period during which <strong>transcription and translation</strong> occurred simultaneously.</li>
  
  <li><strong>Measurement:</strong> Gene expression was measured through a <strong>dual-luciferase assay</strong>. Finally, we plotted and analyzed the results in <strong>RStudio</strong> and prepared a presentation to share with our PI and instructors.</li>
</ol>
<br><br>
<h3>Other Procedures</h3>

<ul>
  <li><strong>Split:</strong> This routine procedure in the team is used to replace the medium of <strong>HEK293T cells</strong> with trypsin, thereby ensuring their survival over time.</li>
  
  <li><strong>Toxicity assay:</strong> This procedure involves seeding cells at different densities and treating them with increasing concentrations of <strong>theophylline</strong>, in order to establish toxicity thresholds.</li>
</ul>

<p>More information about lab procedures and protocols can be found at the <a class="link-text" href="https://2025.igem.wiki/barcelona-ub/notebook">Notebook section</a>.</p>
<br><br>
<h2><a class="link-text" href="https://2025.igem.wiki/barcelona-ub/parts">Constructs </a> used in the lab</h2>
<br>
<p>Classification of the constructs that we used in the lab</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/constructs.webp" 
    alt="General Constructs" 
    style="width: 80%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>
<br>
<br>

<h3>SCR-D</h3>
<p><strong>A: Normal SCR-D (TGA):</strong> This construct is the complete SCR-D along with the STOP codon on which it must act to produce readthrough, allowing the ribosome to bypass it. This way, Firefly luciferase will be expressed.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/tganormal.webp" 
    alt="Normal SCR-D (TGA)" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>
<br>
<h3>B: SCR-D controls</h3>
<p><strong>1- CGA:</strong> This construct has the first nucleotide of the STOP codon mutated from T to C, so the codon is no longer a STOP codon but instead encodes an arginine. In other words, each reading of the constructâ€™s mRNA gives rise to both luciferase proteins, Renilla and Firefly. This serves to normalize the activity of the two luciferases and to generate cleaner and more reliable graphs.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/cga.webp" 
    alt="CGA construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>

<p><strong>2- TAAA:</strong> This construct serves as a negative control for the Dual-Luciferase Assay. In this case, the STOP codon was modified by changing its central nucleotide (G â†’ A) and adding one extra nucleotide immediately after it, introducing a frameshift. As a result, even if the ribosome continues translation beyond this point, the downstream Firefly luciferase gene will be out of frame and cannot be correctly translated. Therefore, no Firefly signal should be detected. This control ensures that any measured Firefly activity in experimental constructs truly results from readthrough events rather than from frameshifting or reinitiation.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/taaa.webp" 
    alt="TAAA construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>

<p><strong>3- TGA postATG mutated:</strong> This construct was designed to control for ribosomal reinitiation. In the natural SCR-D sequence, there is an internal ATG start codon located downstream of the stop codon. This ATG could allow the ribosome to detach and then reinitiate translation, leading to Firefly luciferase expression that is not due to true readthrough. To prevent this, the internal ATG was mutated in a way that preserved the SCR-D RNA structure while eliminating the reinitiation site. As a result, any Firefly luciferase produced from this construct must come exclusively from readthrough events. By comparing this construct to the normal SCR-D (TGA) construct, we can quantify and subtract the contribution of reinitiation.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/atgmutated.webp" 
    alt="TGA postATG mutated construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>
<br>
<h2>C: SCR-D parts</h2>
<br>
<br>
<p><strong>1- Only pre-diapin:</strong> This construct contains only the Pre-diapin region of SCR-D, and it is used to test whether this isolated part is capable of producing readthrough on its own. It allows us to quantify the percentage contribution of Pre-diapin to readthrough, if it is indeed able to induce it.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/onlyprediapin.webp" 
    alt="SCR-D pre-diapin construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>
<br>
<p><strong>2- No hypopin:</strong> This construct contains all parts of SCR-D except for the Hypopin. It is used to determine whether this region is essential for readthrough to occur, or if SCR-D can bypass the STOP codon without it. It allows us to quantify the percentage contribution of Hypopin to readthrough.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/nohypopin.webp" 
    alt="SCR-D no hypopin construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>
<br>
<p><strong>3- Mutated Diapin:</strong> This construct is nearly identical to the normal SCR-D (TGA) element, except that the nucleotide sequence of the Diapin region was altered while maintaining its predicted base pairing and secondary structure. It was designed to determine whether the Diapinâ€™s specific sequence is essential for promoting readthrough, or whether its structural configuration alone is sufficient for SCR-D function. This distinction is particularly important for our project, as we are exploring structure-dependent mechanisms to build a riboswitch.</p>
<div style="text-align: center; margin: 20px 0;">
  <img 
    src="https://static.igem.wiki/teams/5622/images/wetlab/mutateddiapin.webp" 
    alt="SCR-D mutated diapin construct" 
    style="width: 70%; border-radius: 10px; box-shadow: 0 4px 12px rgba(0,0,0,0.3);"
  >
</div>
<br>

</div>
</div>
<style>

.calendar-container {
    background: white;
    border-radius: 20px;
    box-shadow: 0 20px 40px rgba(0,0,0,0.1);
    overflow: hidden;
    margin-bottom: 2rem;
    margin-top: 2rem;
}

.calendar-header {
    background: linear-gradient(135deg, var(--color-intense-1), var(--main-color));
    color: white;
    padding: 2rem;
    text-align: center;
}

.calendar-title {
    font-size: 2rem;
    font-weight: 600;
    margin-bottom: 0.5rem;
}

.calendar-subtitle {
    font-size: 1rem;
    opacity: 0.9;
}

.week-grid {
    display: grid;
    grid-template-columns: repeat(7, 1fr);
    gap: 0;
}

.day-card {
    padding: 2rem 1.5rem;
    border-right: 1px solid var(--color-soft-1);
    border-bottom: 1px solid var(--color-soft-1);
    min-height: 300px;
    position: relative;
    transition: all 0.3s ease;
}

.day-card:hover {
    background: var(--bg-main);
    transform: translateY(-2px);
    box-shadow: var(--shadow);
}

.day-card:last-child {
    border-right: none;
}

.day-header {
    display: flex;
    align-items: center;
    margin-bottom: 1.5rem;
}

.day-number {
    width: 40px;
    height: 40px;         
    min-width: 40px;      
    min-height: 40px;
    border-radius: 50%;
    display: flex;
    align-items: center;
    justify-content: center;
    font-weight: 600;
    font-size: 1.1rem;
    margin-right: 1rem;
    flex-shrink: 0;        
    background: linear-gradient(135deg, var(--color-soft-3), var(--color-intense-1));
    color: white;
}


.day-name {
    font-size: 1.2rem;
    font-weight: 600;
    color: var(--text);
}

.day-content {
    font-size: 0.95rem;
    line-height: 1.6;
    color: var(--grey);
}

.activity-title {
    font-weight: 600;
    color: var(--text);
    margin-bottom: 0.5rem;
    font-size: 1rem;
}

.activity-description {
    margin-bottom: 1rem;
}



.weekend-card {
    grid-column: span 2;
    background: linear-gradient(135deg, var(--color-soft-1), var(--color-soft-2));
    color: var(--text);
}

.weekend-card .day-number {
    background: linear-gradient(135deg, var(--color-intense-2), var(--main-color));
}

.icon {
    font-size: 1.5rem;
    margin-bottom: 1rem;
    display: block;
}

.process-flow {
    background: white;
    border-radius: 15px;
    padding: 2rem;
    box-shadow: 0 10px 30px rgba(0,0,0,0.1);
    margin-top: 2rem;
}

.flow-title {
    text-align: center;
    font-size: 1.8rem;
    font-weight: 600;
    margin-bottom: 2rem;
    color: var(--text);
}

.flow-description {
    text-align: center;
    font-size: 1.1rem;
    color: var(--grey);
    line-height: 1.6;
    max-width: 800px;
    margin: 0 auto;
}
@media (max-width: 1024px) {
    .week-grid {
        grid-template-columns: repeat(2, 1fr); /* 2 columnas para tablets */
    }
    
    .weekend-card {
        grid-column: 1 / -1; /* sigue ocupando todo el ancho */
    }
}

@media (max-width: 768px) {
    .week-grid {
        grid-template-columns: 1fr; /* mÃ³vil: 1 columna por fila */
    }
    
    .weekend-card {
        grid-column: 1 / -1;
    }
}

.emoji {
    font-size: 1.2rem;
    margin-right: 0.5rem;
}

.week-grid {
    display: grid;
    grid-template-columns: repeat(5, 1fr); /* lunes a viernes */
    gap: 1px;
}

.weekend-card {
    grid-column: 1 / -1; /* ocupa todas las columnas debajo de la semana */
}

.parts-table {
    width: 100%;
    table-layout: fixed; 
    border-collapse: collapse;
    border-spacing: 0;
  }
.parts-table th{
  background-color: var(--color-soft-1);
}
.parts-table th, .parts-table td {
    word-wrap: break-word; 
  }
</style>

{% endblock %}
